James Kasuboski

Company: Luma Group

Job title: Partner & Head of Research

Bio:

Jamie Kasuboski, Ph.D., has 15 years in biomedical research and over a decade in Biotech and Pharma. He has invested in 18+ companies from pre-clinical to clinical stages, securing follow-on capital and partnerships. Formerly an investor at OMX Ventures, RA Capital, and Boehringer Ingelheim Venture Fund, he specializes in preclinical/clinical therapeutics and research tools. His research background spans academia and industry, holding a Ph.D. in Cell and Molecular Biology from the University of Notre Dame and a B.S. in Biology with a Chemistry minor from Hillsdale College. He combines deep scientific expertise with proven investment and company-building experience.

Seminars:

Interview the Investor: Engaging Investor Perspectives on Ophthalmic Gene Therapy Investment Criteria to Unlock Funding Opportunities for Novel Ocular Gene Therapies 11:30 am

Understanding investor requirements for clinical efficacy data and risk mitigation strategies to meet evolving investment standards Exploring alternative value propositions for investment to address rare market size limitations Identifying strategic partnership opportunities and funding diversification approaches to make gene therapy development financially sustainableRead more

day: Conference Day Two